Publication:
SELNET clinical practice guidelines for soft tissue sarcoma and GIST

dc.contributor.authorBlay, JY
dc.contributor.authorHindi, N
dc.contributor.authorBollard, J
dc.contributor.authorAguiar, S
dc.contributor.authorAngel, M
dc.contributor.authorAraya, B
dc.contributor.authorBadilla, R
dc.contributor.authorBernabeu, D
dc.contributor.authorCampos, F
dc.contributor.authorCaro-Sánchez, CHS
dc.contributor.authorCarvajal, B
dc.contributor.authorCarvajal Montoya, A
dc.contributor.authorCasavilca-Zambrano, S
dc.contributor.authorCastro-Oliden V
dc.contributor.authorChacón, M
dc.contributor.authorClara, M
dc.contributor.authorCollini, P
dc.contributor.authorCorrea-Genoroso, R
dc.contributor.authorCosta, FD
dc.contributor.authorCuellar, M
dc.contributor.authordei Tos, AP
dc.contributor.authorDominguez Malagon, HR
dc.contributor.authorDonati, A
dc.contributor.authorDufresne, A
dc.contributor.authorEriksson, M
dc.contributor.authorFarias-Loza, M
dc.contributor.authorFernandez, P
dc.contributor.authorFrezza, AM
dc.contributor.authorFrisoni, T
dc.contributor.authorGarcia-Ortega, DY
dc.contributor.authorGelderblom, H
dc.contributor.authorGouin, F
dc.contributor.authorGómez-Mateo, MC
dc.contributor.authorGronchi, A
dc.contributor.authorHaro, J
dc.contributor.authorHuanca, L
dc.contributor.authorJimenez, N
dc.contributor.authorKaranian, M
dc.contributor.authorKasper, B
dc.contributor.authorLopes David, BB
dc.contributor.authorLopez-Pousa, A
dc.contributor.authorLutter, G|Martinez-Said, H
dc.contributor.authorMartinez-Tlahuel, J
dc.contributor.authorMello, CA
dc.contributor.authorMorales-Pérez, JM
dc.contributor.authorMoura-David, S
dc.contributor.authorNascimento, AG
dc.contributor.authorOrtiz-Cruz, EJ
dc.contributor.authorPalmerini, E
dc.contributor.authorPatel, S
dc.contributor.authorPfluger, Y
dc.contributor.authorProvenzano, S
dc.contributor.authorRighi, A
dc.contributor.authorRodriguez, A
dc.contributor.authorSalas, R
dc.contributor.authorSantos, TTG
dc.contributor.authorScotlandi, K
dc.contributor.authorSoule, T
dc.contributor.authorStacchiotti, S
dc.contributor.authorValverde, C
dc.contributor.authorWaisberg, F
dc.contributor.authorZamora Estrada, E
dc.contributor.authorMartin-Broto, J
dc.date.accessioned2025-01-02T14:42:53Z
dc.date.available2025-01-02T14:42:53Z
dc.date.issued2022
dc.description.abstractSoft tissue sarcoma (STS) is a heterogeneous group of neoplasms, encompassing > 80 different histologic subtypes. Approximately three quarter of sarcoma arise from soft-tissue, about 15% are gastrointestinal stromal tumours (GISTs) and bone sarcoma represent the remaining 10%. The current guidelines will focus on soft-tissue and GIST, excluding Kaposi sarcoma and non-pleomorphic rhabdomyosarcoma. Bone sarcomas are covered in a different paper.
dc.formatapplication/pdf
dc.identifier.doihttps: //doi.org/10.1016/j.ctrv.2021.102312
dc.identifier.journalCancer Treatment Reviews
dc.identifier.urihttps://hdl.handle.net/20.500.14703/341
dc.language.isoeng
dc.publisherW.B. Saunders Ltd
dc.publisher.countryUK
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/
dc.subjectGastrointestinal Stromal Tumors
dc.subjectGuidelines as Topic
dc.subjectHumans
dc.subjectLatin America
dc.subjectSarcoma
dc.subjectSoft Tissue Neoplasms
dc.subject.ocdehttps://purl.org/pe-repo/ocde/ford#3.02.21
dc.titleSELNET clinical practice guidelines for soft tissue sarcoma and GIST
dc.typeinfo:eu-repo/semantics/review
dc.type.versioninfo:eu-repo/semantics/publishedVersion
dspace.entity.typePublication

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
PIIS0305737221001602.pdf
Size:
1.46 MB
Format:
Adobe Portable Document Format